View the ADAMAKS registration information details.
Back to drug list
ItemsDrug Registration information
ID857
No857
Brand NameADAMAKS
IngredientsADAGRASIB 200 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack Size30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULT PATIENTS WITH KRAS G12C MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT YELLOW , FILM COATED TABLET
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY NO. 2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 L 1347/25
FDD Registration Date30/04/2025
Expiry Date29/04/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA